PointState Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-95,935	Closed	-$14.7M	–	188
2021 Q1	$14.7M	Sell	95,935 -37,186	-28%	-$5.75M	0.41%	66
2020 Q4	$20.8M	Buy	133,121 +98,121	+280%	+$12.6M	0.52%	55
2020 Q3	$4M	Sell	35,000 -116,417	-77%	-$12.6M	0.14%	73
2020 Q2	$17M	Buy	151,417 +133,917	+765%	+$14.2M	0.65%	40
2020 Q1	$1.57M	Sell	17,500 -211,910	-92%	-$20.8M	0.1%	50
2019 Q4	$24.8M	Buy	+229,410	New	+$24.5M	0.68%	50
2019 Q2	–	Sell	-4,000	Closed	-$539K	–	177
2019 Q1	$539K	Buy	+4,000	New	+$497K	0.01%	121
2018 Q3	–	Sell	-707,800	Closed	-$87.9M	–	208
2018 Q2	$87.9M	Buy	707,800 +275,400	+64%	+$32.2M	1.06%	29
2018 Q1	$48.2M	Buy	+432,400	New	+$51.7M	0.55%	55
2017 Q2	–	Sell	-79,700	Closed	-$9.66M	–	189
2017 Q1	$9.66M	Sell	79,700 -1,029,250	-93%	-$133M	0.12%	100
2016 Q4	$136M	Buy	1,108,950 +915,250	+473%	+$112M	2.26%	13
2016 Q3	$23.7M	Buy	+193,700	New	+$24.9M	0.33%	70
2015 Q2	–	Sell	-110,000	Closed	-$19.1M	–	191
2015 Q1	$19.1M	Buy	+110,000	New	+$19.9M	0.28%	66